tradingkey.logo
tradingkey.logo
Search

Aurobindo Pharma Says Co Receives USFDA Approval For Dapagliflozin Tablets, 5 Mg And 10 Mg

ReutersApr 7, 2026 12:48 PM

- Aurobindo Pharma Ltd ARBN.NS:

  • AUROBINDO PHARMA - AUROBINDO PHARMA RECEIVES USFDA APPROVAL FOR DAPAGLIFLOZIN TABLETS, 5 MG AND 10 MG

  • AUROBINDO PHARMA - ELIGIBLE FOR 180 DAYS SHARED GENERIC DRUG EXCLUSIVITY FOR DAPAGLIFLOZIN TABLETS

Source text: https://tinyurl.com/rdf89uy8

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI